Apoptosis in squamous cell carcinoma of the lung: correlation with survival and clinicopathological features

M Ghosh¹, J Crocker², A Morris³

¹ Westbank Hospital, Andul Road, Howrah 711109, India
² Department of Histopathology, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B5 5ST, UK
³ Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK

Correspondence to:
Dr MorrisAMorris{at}bio.warwick.ac.uk

Aims—Apoptosis is recognised as a physiological mechanism for controlling cell numbers and its subversion is thought to contribute to carcinogenesis. The aims of this study were to measure the apoptotic index (AI) in a series of squamous cell carcinomas (SCCs) of the lung using standard histological staining and confirm this by immunohistology using an antibody to an apoptosis specific protein (ASP), and to seek to correlate the AI with clinicopathological parameters.

Methods—Sections of 134 SCCs were stained by haematoxylin and eosin (H&E) for counting apoptotic bodies to determine the AI (number of apoptotic bodies/10 000 tumour cells); 26 of these were also stained with anti-ASP antibody and the proportion of ASP positive cells counted. Clinical data were obtained from hospital notes.

Results—The mean AI obtained by H&E staining of all 134 SCCs was 30.3 (SD, 24.75). Anti-ASP staining allowed easy identification of apoptotic bodies, and generated a somewhat higher index (mean, 51.4; SD 39); this was not a result of the selection of tumours because the AI by H&E in the subset stained with anti-ASP was 31.1. Regression analysis showed that the correlation between the two values of AI was highly significant (Rs = 0.9760; p < 0.001), indicating that the two methods were both reliable measures of apoptosis but that the anti-ASP staining is the more sensitive method. The tumours were grouped into high AI (> 50) and low AI (< 50) and survival analysis was carried out. The mean survival of the high AI group was 109 weeks and of the low AI group 72 weeks (p = 0.036).

Conclusions—Anti-ASP staining is a reliable, easy, and sensitive method for assessing apoptosis in tumour sections and confirms the validity of the AI obtained by H&E staining. AI is a guide to the behaviour of SCCs of the lung.

Key Words: apoptosis • squamous cell carcinoma • lung • apoptosis specific protein • prognosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Mi, Y., Thomas, S. D., Xu, X., Casson, L. K., Miller, D. M., Bates, P. J. (2003). Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin. J. Biol. Chem. 278: 8572-8579 [Abstract] [Full Text]  
• Belhocine, T., Steinmetz, N., Hustinx, R., Bartsch, P., Jerusalem, G., Seidel, L., Rigo, P., Green, A. (2002). Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis. Clin. Cancer Res. 8: 2766-2774 [Abstract] [Full Text]